Page last updated: 2024-08-24

3-iodobenzylguanidine and Emesis

3-iodobenzylguanidine has been researched along with Emesis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bleeker, G; Caron, HN; de Kraker, J; Hoefnagel, CA; Schoot, RA; Tytgat, GA; van Eck, BL1
Listernick, R1

Trials

1 trial(s) available for 3-iodobenzylguanidine and Emesis

ArticleYear
Toxicity of upfront ¹³¹I-metaiodobenzylguanidine (¹³¹I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:11

    Topics: 3-Iodobenzylguanidine; Anemia; Child; Child, Preschool; Female; Humans; Infant; Male; Nausea; Neuroblastoma; Radiopharmaceuticals; Retrospective Studies; Thrombocytopenia; Vomiting

2013

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Emesis

ArticleYear
An 11-year-old boy with emesis, decreased appetite, fever.
    Pediatric annals, 2010, Volume: 39, Issue:12

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Appetite; Blood Pressure; Cardiomyopathy, Hypertrophic; Child; Diagnosis, Differential; Fever; Humans; Male; Paraganglioma, Extra-Adrenal; Pheochromocytoma; Radiopharmaceuticals; Vomiting

2010